Thyroid Eye Disease (TED), also known as thyroid orbitopathy, is a complex condition that can cause swelling, discomfort, and changes to the appearance and function of the eyes. Common in individuals with autoimmune thyroid disorders like Graves’ disease, TED can significantly impact quality of life if left untreated.
One of the most advanced treatments for TED is TEPEZZA, a groundbreaking medication that targets the underlying causes of the condition. Dr. Robert Schwarcz, with offices on the Upper East Side of Manhattan in NYC and Rye, NY, offers expert care and guidance for individuals seeking relief from TED.
What Is TEPEZZA?
TEPEZZA is the first FDA-approved medication specifically for Thyroid Eye Disease. It works by targeting and blocking the activity of IGF-1R (insulin-like growth factor-1 receptor), which plays a key role in the inflammatory process that causes TED.
How TEPEZZA Works
Targets Inflammation: Reduces swelling and redness in the tissues surrounding the eyes.
Improves Symptoms: Addresses symptoms like bulging eyes (proptosis), double vision (diplopia), and discomfort.
Restores Functionality: Helps restore normal eye function and improve appearance over time.
What to Expect During TEPEZZA Treatment
1. Infusion Process
TEPEZZA is administered through an intravenous (IV) infusion.
Patients typically receive one infusion every three weeks, for a total of eight infusions.
Each infusion lasts approximately 60–90 minutes.
2. Results
Many patients notice improvements in symptoms within the first few treatments.
TEPEZZA has been shown to reduce proptosis, improve double vision, and significantly enhance overall quality of life.
Who Is a Candidate for TEPEZZA?
TEPEZZA may be suitable for individuals who:
Are in the active phase of Thyroid Eye Disease (when inflammation and tissue changes are occurring).
Experience symptoms such as bulging eyes, redness, swelling, or double vision.
Are not candidates for surgical intervention or prefer a non-surgical treatment option.
Dr. Schwarcz will evaluate your condition and medical history to determine if TEPEZZA is the right option for you.
Benefits of TEPEZZA
Non-Surgical: Offers a less invasive alternative to surgical treatments for TED.
Targeted Relief: Addresses the root cause of inflammation and symptoms.
Proven Results: Clinical trials have shown significant improvements in proptosis, double vision, and quality of life.
Convenient Schedule: Infusions every three weeks make the treatment manageable for most patients.
Additional Treatment Options
While TEPEZZA is highly effective for many patients, some individuals may require surgical options for long-term management or advanced cases of TED. These options include:
Orbital Decompression Surgery: Reduces pressure in the eye sockets and corrects proptosis.
Eyelid Surgery: Improves eyelid position and restores natural appearance.
Dr. Schwarcz specializes in these procedures and can provide a comprehensive plan to address all aspects of your condition.
Why Choose Dr. Robert Schwarcz for TED Treatment?
Dr. Robert Schwarcz is a renowned oculofacial plastic surgeon with extensive experience treating Thyroid Eye Disease. His holistic approach ensures that patients receive the most effective treatment for their specific needs, whether through TEPEZZA or surgical interventions.
With offices on the Upper East Side of Manhattan in NYC and Rye, NY, Dr. Schwarcz provides compassionate, expert care in a professional and welcoming environment.
Take Control of Thyroid Eye Disease Today
If you’re living with Thyroid Eye Disease, TEPEZZA offers a revolutionary treatment to reduce symptoms and improve your quality of life. Schedule a consultation with Dr. Schwarcz to learn more about this innovative therapy and explore your options for relief. Request an appointment by clicking the button below to take the first step toward clearer, more comfortable vision.
Comments